肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 共识文件：接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测

2020-10-23 国外肿瘤科相关专家小组（统称） Oncol Res Treat . 2020 Oct 23;43(11):628-636.

卡培他滨5-氟尿嘧啶

5-氟尿嘧啶是肿瘤系统性治疗中最常用到的细胞抑制药物之一，应用该药治疗可引起严重或致命性副作用。本文主要针对肿瘤患者在接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测提供共识建议。

中文标题：

2020 共识文件：接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测

英文标题：

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

发布机构：

国外肿瘤科相关专家小组（统称）

发布日期：

2020-10-23

简要介绍：

5-氟尿嘧啶是肿瘤系统性治疗中最常用到的细胞抑制药物之一，应用该药治疗可引起严重或致命性副作用。本文主要针对肿瘤患者在接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测提供共识建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 共识文件：接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2377f1c0020022e3, title=2020 共识文件：接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测, enTitle=Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper, guiderFrom=Oncol Res Treat . 2020 Oct 23;43(11):628-636., authorId=0, author=, summary=5-氟尿嘧啶是肿瘤系统性治疗中最常用到的细胞抑制药物之一，应用该药治疗可引起严重或致命性副作用。本文主要针对肿瘤患者在接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测提供共识建议。, cover=https://img.medsci.cn/20201031/1604074693026_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Fri Oct 23 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>5-氟尿嘧啶是肿瘤系统性治疗中最常用到的细胞抑制药物之一，应用该药治疗可引起严重或致命性副作用。本文主要针对肿瘤患者在接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测提供共识建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=982, tagName=卡培他滨), TagDto(tagId=5502, tagName=5-氟尿嘧啶)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5502, guiderKeyword=5-氟尿嘧啶, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2055, appHits=61, showAppHits=0, pcHits=721, showPcHits=1994, likes=0, shares=7, comments=3, approvalStatus=1, publishedTime=Sat Oct 31 00:51:53 CST 2020, publishedTimeString=2020-10-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 00:18:18 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 21:57:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 共识文件：接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测.pdf)])
2020 共识文件：接受5-氟尿嘧啶、卡培他滨和替加氟治疗前的二氢嘧啶脱氢酶检测.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=898059, encodeId=a049898059b8, content=临床上非常有指导意义，该项目的检测已成为我肿瘤内科临床常规。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/307eaafaa27142bfa7ec775555f8ff8c/b6e989d92e904e968fe6e5409b3f4fe7.jpg, createdBy=73405431216, createdName=悠弦momo, createdTime=Mon Nov 09 20:34:27 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896097, encodeId=559b89609e81, content=谢谢！有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAaT49BWZ5LsjicVar1PlKKvBXEsXXrLHrWib9drOX9EEGSEXjKuR4fthe8DvkdPxVxlMU54spB6VA/132, createdBy=463a2037573, createdName=chiefland, createdTime=Sun Nov 01 20:05:15 CST 2020, time=2020-11-01, status=1, ipAttribution=)]
    2020-11-09 悠弦momo

    临床上非常有指导意义，该项目的检测已成为我肿瘤内科临床常规。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=898059, encodeId=a049898059b8, content=临床上非常有指导意义，该项目的检测已成为我肿瘤内科临床常规。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/307eaafaa27142bfa7ec775555f8ff8c/b6e989d92e904e968fe6e5409b3f4fe7.jpg, createdBy=73405431216, createdName=悠弦momo, createdTime=Mon Nov 09 20:34:27 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896097, encodeId=559b89609e81, content=谢谢！有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAaT49BWZ5LsjicVar1PlKKvBXEsXXrLHrWib9drOX9EEGSEXjKuR4fthe8DvkdPxVxlMU54spB6VA/132, createdBy=463a2037573, createdName=chiefland, createdTime=Sun Nov 01 20:05:15 CST 2020, time=2020-11-01, status=1, ipAttribution=)]
    2020-11-01 chiefland

    谢谢！有指导意义

    0